| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Pricing By Demand Instead of By Purchase Price |
|
Advice You - Pricing By Demand Instead of By Purchase Price
Don't consider your dog inventory to be savings Everyone makes mistakes when buying inventory. Some According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product items sell consistently well while others move slowly. Many retailers have a hard time discounting the slow ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in movers and dropping the item from inventory. They feel that because the item is still in stock and may eventu lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. lly sell at the desired price then the accumulated inventory is like a savings account. If you consider your here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe poor selling items as savings, however, you have invested your life’s work in a poor investment. What happen d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s is that over time your inventory mix gets choked with the accumulated poor sellers. You inventory is compo ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ed of items past customers avoided in favor of better sellers. Jewelers do this all the time. They buy a par easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi cel of (5) one carat diamonds and apply a standard markup to them all. They sell the three nice cuts fast, t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hen sell the average cut in a normal time, and the poorly cut diamond sits in their inventory as "savings". O and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ er time, the dealer's inventory consists of these poorly cut stones but is supposedly worth $100K. In reali ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ty, however, it is worth less than that because the $100K represents the book value and not the market value. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a The better method is to sell the premium stones at a premium price, the average stone at an average price, dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nd the poorly cut stone at a discount. It averages out to a normal profit but keeps all the money in play so cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin you can purchase the next parcels of five diamonds. The need for this system becomes even more critical when tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the inventory is subject to spoilage like clothing. At the beginning of the season people pay a premium but t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel by the end of the season the retailer is looking at carrying these off season items for six months in storage ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust . Worse, the items can go out of style before the next season and may never sell. Large retailers already i y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products mplement this system of selling high at the beginning of the season and discounting to liquidation at the end . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de of the season. Even if your goods are not seasonal, your cash flow and turnover will benefit by selling the elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip best goods at a premium and the dogs at a discount until liquidated. Don't let your dogs become your savings tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Service Quality Context: It's Everywhere! Starting An Entrepreneur Magazine Business 4 Tips To Ensure A Rewarding Experience When Hiring Others
|